01

CIndU Care: Antihistamine Up-Titration Anchors a Still-Gappy Algorithm

CIndU management still hinges on up-titrating H1-antihistamines up to fourfold, but experts flag thin subtype-specific evidence and a sparse pipeline beyond omalizumab.